More

    BTS’ Jimin’s “Who” reigns at #1 on global Spotify chart for two consecutive days

    Jimin of BTS has once again made headlines with his second solo album‘s title track, “Who,” which has clinched the #1 spot on the global Spotify chart for two consecutive days, July 23rd and 24th. This achievement underscores the song’s remarkable success and Jimin’s growing influence in the global music scene.

    - ADVERTISEMENT -

    “Who” dominates Spotify with record-breaking streams

    Jimin’s title track “Who” from his album ‘MUSE‘ has topped the global Spotify chart. It has also recorded the highest number of daily streams among K-pop songs released this year. Since entering the Daily Top Song Global chart at number 3 on July 19th, “Who“. The song held the Top 5 spot and impressively returned to #1 on its fifth release day.

    Soaring to new heights in the US and beyond

    “Who” reached its highest ranking on the Daily Top Song US chart on July 24th, rising three spots to #3. The song’s global appeal is further highlighted by its consistent #1 position on the Daily Top Song charts in 16 countries and regions, including Korea, Vietnam, Singapore, and Paraguay.

    - ADVERTISEMENT -
    BTS' Jimin's "Who" reigns at #1 on global Spotify chart for two consecutive days
    Image Courtesy: Spotify

    The allure of “Who”: Music and lyrics

    “Who” features a captivating hip-hop R&B blend, characterized by its strong bounce and impressive guitar performance. The song’s addictive beat, combined with Jimin’s dynamic performance, has contributed to its widespread popularity. Lyrically, “Who” explores the poignant emotions of longing and confusion associated with missing someone never met. The track‘s combination of a catchy rhythm and the heartfelt lyrics of “I want to find true love” resonates deeply with listeners.

    Source:(1)
    Via:(1)

    Stay in the Loop

    Get the daily email from Oneily News that makes reading the news actually enjoyable. Join our mailing list to stay in the loop to stay informed, for free.

    Latest stories

    - Advertisement -